These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
250 related items for PubMed ID: 24471407
21. Possible role of nitric oxide in visceral hypersensitivity in patients with irritable bowel syndrome. Kuiken SD, Klooker TK, Tytgat GN, Lei A, Boeckxstaens GE. Neurogastroenterol Motil; 2006 Feb; 18(2):115-22. PubMed ID: 16420289 [Abstract] [Full Text] [Related]
22. Visceral hypersensitivity in irritable bowel syndrome. Kanazawa M, Hongo M, Fukudo S. J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723 [Abstract] [Full Text] [Related]
23. Gastric ulcer healing and stress-lesion preventive properties of pioglitazone are attenuated in diabetic rats. Konturek PC, Brzozowski T, Burnat G, Szlachcic A, Koziel J, Kwiecien S, Konturek SJ, Harsch IA. J Physiol Pharmacol; 2010 Aug; 61(4):429-36. PubMed ID: 20814070 [Abstract] [Full Text] [Related]
24. Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, induces dilation of isolated porcine retinal arterioles: role of nitric oxide and potassium channels. Omae T, Nagaoka T, Tanano I, Yoshida A. Invest Ophthalmol Vis Sci; 2011 Aug 24; 52(9):6749-56. PubMed ID: 21757589 [Abstract] [Full Text] [Related]
25. Pharmacological properties of 3-amino-5,6,7,8-tetrahydro-2-[4-[4-(quinolin-2-yl)piperazin-1-yl]butyl]quinazolin-4(3H)-one (TZB-30878), a novel therapeutic agent for diarrhea-predominant irritable bowel syndrome (IBS) and its effects on an experimental IBS model. Tamaoki S, Yamauchi Y, Nakano Y, Sakano S, Asagarasu A, Sato M. J Pharmacol Exp Ther; 2007 Sep 24; 322(3):1315-23. PubMed ID: 17540858 [Abstract] [Full Text] [Related]
26. Inhibitory effects of patchouli alcohol on stress-induced diarrhea-predominant irritable bowel syndrome. Zhou TR, Huang JJ, Huang ZT, Cao HY, Tan B. World J Gastroenterol; 2018 Feb 14; 24(6):693-705. PubMed ID: 29456408 [Abstract] [Full Text] [Related]
27. Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome. Zou BC, Dong L, Wang Y, Wang SH, Cao MB. Chin Med J (Engl); 2007 Dec 05; 120(23):2069-74. PubMed ID: 18167178 [Abstract] [Full Text] [Related]
28. [Effect of Fagopyrum cymosum (Trev.) Meisn alcohol extract on defecation and isolated colon of diarrhea-IBS rats and its mechanism]. Liu LN, Yan J, Sun ZG. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Dec 05; 34(12):1469-75. PubMed ID: 25632748 [Abstract] [Full Text] [Related]
29. Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P. Yin Y, Zhong L, Wang JW, Zhao XY, Zhao WJ, Kuang HX. World J Gastroenterol; 2015 Apr 21; 21(15):4536-46. PubMed ID: 25914462 [Abstract] [Full Text] [Related]
30. Protective effect of pharmacologic preconditioning with pioglitazone on random-pattern skin flap in rat is mediated by nitric oxide system. Afraz S, Kamran A, Moazzami K, Nezami BG, Dehpour AR. J Surg Res; 2012 Aug 21; 176(2):696-700. PubMed ID: 22137986 [Abstract] [Full Text] [Related]
31. Antinociceptive effect of VSL#3 on visceral hypersensitivity in a rat model of irritable bowel syndrome: a possible action through nitric oxide pathway and enhance barrier function. Dai C, Guandalini S, Zhao DH, Jiang M. Mol Cell Biochem; 2012 Mar 21; 362(1-2):43-53. PubMed ID: 22020749 [Abstract] [Full Text] [Related]
32. Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome. Zakko S, Barton G, Weber E, Dunger-Baldauf C, Rühl A. Aliment Pharmacol Ther; 2011 Jun 21; 33(12):1311-21. PubMed ID: 21507028 [Abstract] [Full Text] [Related]
33. Effect of water extract from Berberis heteropoda Schrenk roots on diarrhea-predominant irritable bowel syndrome by adjusting intestinal flora. Zhu HM, Li L, Li SY, Yan Q, Li F. J Ethnopharmacol; 2019 Jun 12; 237():182-191. PubMed ID: 30902748 [Abstract] [Full Text] [Related]
34. Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii. Bafutto M, Almeida JR, Leite NV, Costa MB, Oliveira EC, Resende-Filho J. Arq Gastroenterol; 2013 Jun 12; 50(4):304-9. PubMed ID: 24474234 [Abstract] [Full Text] [Related]
35. Role of PPAR gamma/nitric oxide synthase signaling in the cyclosporine-induced attenuation of endothelium-dependent renovascular vasodilation. Abd-Elrahman KS, El-Gowelli HM, Saad EI, Abdel-Galil AG, El-Mas MM. J Cardiovasc Pharmacol; 2010 Aug 12; 56(2):195-202. PubMed ID: 20505521 [Abstract] [Full Text] [Related]
36. Translational evaluation of Gelsectan® effects on gut barrier dysfunction and visceral pain in animal models and irritable bowel syndrome with diarrhoea. Inczefi O, Eutamene H, Placide F, Tondereau V, Pallagi P, Bagyánszki M, Bódi N, Gémes N, Szebeni G, Molnár T, Theodorou V, Róka R. United European Gastroenterol J; 2024 Oct 12; 12(8):1102-1113. PubMed ID: 39106086 [Abstract] [Full Text] [Related]
37. Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner. Chen C, Lu M, Pan Q, Fichna J, Zheng L, Wang K, Yu Z, Li Y, Li K, Song A, Liu Z, Song Z, Kreis M. PLoS One; 2015 Oct 12; 10(12):e0145556. PubMed ID: 26700862 [Abstract] [Full Text] [Related]
38. Otilonium Bromide treatment prevents nitrergic functional and morphological changes caused by chronic stress in the distal colon of a rat IBS model. Traini C, Idrizaj E, Garella R, Faussone-Pellegrini MS, Baccari MC, Vannucchi MG. J Cell Mol Med; 2021 Jul 12; 25(14):6988-7000. PubMed ID: 34109728 [Abstract] [Full Text] [Related]
39. Ginger relieves intestinal hypersensitivity of diarrhea predominant irritable bowel syndrome by inhibiting proinflammatory reaction. Zhang C, Huang Y, Li P, Chen X, Liu F, Hou Q. BMC Complement Med Ther; 2020 Sep 14; 20(1):279. PubMed ID: 32928188 [Abstract] [Full Text] [Related]
40. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial. Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L. Aliment Pharmacol Ther; 2005 Feb 15; 21(4):435-44. PubMed ID: 15709995 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]